BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐜 A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.
13 auth. M. Ackerman, B. Moldt, R. Wyatt, Anne-Sophie Dugast, E. Mcandrew, S. Tsoukas, S. Jost, C. Berger, G. Sciaranghella, Qingquan Liu, ... D. Irvine, D. Burton, G. Alter
8 2010
8
🐜
🐜 Definition of the viral targets of protective HIV-1-specific T cell responses
31 auth. B. Mothe, A. Llano, J. Ibarrondo, M. Daniels, C. Miranda, Jennifer Zamarreño, Vanessa Bach, R. Zuñiga, S. Pérez-Álvarez, C. Berger, M. Puertas, J. Martinez-Picado, M. Rolland, M. Farfán, James Szinger, ... W. Hildebrand, O. Yang, V. Sanchez-Merino, C. Brumme, Z. Brumme, D. Heckerman, Todd M. Allen, J. Mullins, G. Gómez, P. Goulder, B. Walker, J. Gatell, B. Clotet, Bette T. Korber, Jorge Sanchez, C. Brander
7 2011
7
🐜
🐬 Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires
Enkelejda Miho, A. Yermanos, Cédric R. Weber, C. Berger, S. Reddy, Victor Greiff
7 2017
7
🐬
🐜 CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control
23 auth. B. Mothe, A. Llano, J. Ibarrondo, Jennifer Zamarreño, Mattia Schiaulini, C. Miranda, M. Ruiz-Riol, C. Berger, M. J. Herrero, E. Palou, ... M. Plana, M. Rolland, A. Khatri, D. Heckerman, F. Pereyra, B. Walker, D. Weiner, R. Paredes, B. Clotet, B. Felber, G. Pavlakis, J. Mullins, C. Brander
7 2012
7
🐜
🦁 High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control
17 auth. C. Berger, N. Frahm, D. Price, B. Mothe, M. Ghebremichael, K. Hartman, Leah M. Henry, J. Brenchley, Laura E. Ruff, Vanessa Venturi, ... F. Pereyra, J. Sidney, A. Sette, D. Douek, B. Walker, D. Kaufmann, C. Brander
7 2011
7
🦁
🐜 Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy
13 auth. P. Błyszczuk, G. Kania, T. Dieterle, René R. Marty, A. Valaperti, C. Berthonneche, T. Pedrazzini, C. Berger, S. Dirnhofer, C. Matter, ... J. Penninger, T. Lüscher, U. Eriksson
6 2009
6
🐜
🐜 Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
18 auth. D. Kroy, D. Ciuffreda, Jennifer H. Cooperrider, M. Tomlinson, Garrett D. Hauck, Jasneet Aneja, C. Berger, David Wolski, M. Carrington, E. Wherry, ... R. Chung, K. Tanabe, N. Elias, G. Freeman, R. de Kruyff, J. Misdraji, A. Kim, G. Lauer
6 2014
6
🐜
🦁 High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
C. Berger, M. Wolbers, P. Meyer, T. Daikeler, C. Hess
6 2009
6
🦁
🐬 Single-cell analysis of the dynamics and functional outcomes of interactions between human natural killer cells and target cells.
Yvonne J. Yamanaka, C. Berger, M. Sips, Patrick C. Cheney, G. Alter, J. C. Love
6 2012
6
🐬
🐜 The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.
8 auth. M. Aschwanden, S. Imfeld, Daniel Staub, T. Baldi, Ulrich A. Walker, C. Berger, ... C. Hess, T. Daikeler
6 2015
6
🐜